PA has shown to be inversely associated with brain amyloid deposition and to a greater extent in APOE ε4 carriers (Head et al., 2012; Brown et al., 2013); however, contradictory results have been reported when examining dementia risk as an outcome measure (Podewils et al., 2005; Rovio et al., 2005). Here, APOE is linked to dementia.